Aromasin Package insert

(Exemestane)

  • Pill
  • Breast cancer
  • Adjuvant
  • Postmenopausal
  • Estrogen receptor-positive
  • Following 2 to 3 years of adjuvant tamoxifen Breast cancer
  • Advanced
Back to: Full Site Navigation

FDA package inserts for Aromasin (Exemestane)

This is the FDA package insert, supplied by pharmaceutical companies

Downloading FDA Package Insert for Aromasin tablet